Display options
Share it on

Front Mol Neurosci. 2018 Mar 20;11:78. doi: 10.3389/fnmol.2018.00078. eCollection 2018.

Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders.

Frontiers in molecular neuroscience

José J Miguel-Hidalgo

Affiliations

  1. Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, United States.

PMID: 29615864 PMCID: PMC5869926 DOI: 10.3389/fnmol.2018.00078

Abstract

Postmortem studies reveal structural and molecular alterations of astrocytes and oligodendrocytes in both the gray and white matter (GM and WM) of the prefrontal cortex (PFC) in human subjects with chronic alcohol abuse or dependence. These glial cellular changes appear to parallel and may largely explain structural and functional alterations detected using neuroimaging techniques in subjects with alcohol use disorders (AUDs). Moreover, due to the crucial roles of astrocytes and oligodendrocytes in neurotransmission and signal conduction, these cells are very likely major players in the molecular mechanisms underpinning alcoholism-related connectivity disturbances between the PFC and relevant interconnecting brain regions. The glia-mediated etiology of alcohol-related brain damage is likely multifactorial since metabolic, hormonal, hepatic and hemodynamic factors as well as direct actions of ethanol or its metabolites have the potential to disrupt distinct aspects of glial neurobiology. Studies in animal models of alcoholism and postmortem human brains have identified astrocyte markers altered in response to significant exposures to ethanol or during alcohol withdrawal, such as gap-junction proteins, glutamate transporters or enzymes related to glutamate and gamma-aminobutyric acid (GABA) metabolism. Changes in these proteins and their regulatory pathways would not only cause GM neuronal dysfunction, but also disturbances in the ability of WM axons to convey impulses. In addition, alcoholism alters the expression of astrocyte and myelin proteins and of oligodendrocyte transcription factors important for the maintenance and plasticity of myelin sheaths in WM and GM. These changes are concomitant with epigenetic DNA and histone modifications as well as alterations in regulatory microRNAs (miRNAs) that likely cause profound disturbances of gene expression and protein translation. Knowledge is also available about interactions between astrocytes and oligodendrocytes not only at the Nodes of Ranvier (NR), but also in gap junction-based astrocyte-oligodendrocyte contacts and other forms of cell-to-cell communication now understood to be critical for the maintenance and formation of myelin. Close interactions between astrocytes and oligodendrocytes also suggest that therapies for alcoholism based on a specific glial cell type pathology will require a better understanding of molecular interactions between different cell types, as well as considering the possibility of using combined molecular approaches for more effective therapies.

Keywords: alcoholism; animal models; epigenetic; glia; human; molecular markers; myelin; postmortem

References

  1. Pharmacol Biochem Behav. 2014 Jan;116:142-51 - PubMed
  2. Alcohol Res. 2013;35(1):69-76 - PubMed
  3. Alcohol. 2017 May;60:67-75 - PubMed
  4. Drug Alcohol Rev. 1990;9(1):53-60 - PubMed
  5. Exp Neurol. 2013 Sep;247:9-18 - PubMed
  6. Brain Res Bull. 2016 Jul;125:1-18 - PubMed
  7. Alcohol Alcohol Suppl. 1994;2:253-7 - PubMed
  8. J Cereb Blood Flow Metab. 2002 Apr;22(4):367-78 - PubMed
  9. Alcohol Clin Exp Res. 2005 Mar;29(3):326-33 - PubMed
  10. Biochem Pharmacol. 2008 Jan 1;75(1):218-65 - PubMed
  11. Trends Neurosci. 2006 Oct;29(10):547-53 - PubMed
  12. J Psychiatr Res. 2003 Sep-Oct;37(5):411-20 - PubMed
  13. J Neurosci. 2012 Feb 1;32(5):1884-97 - PubMed
  14. Neurotox Res. 2013 Jan;23(1):105-10 - PubMed
  15. Prog Neurobiol. 2009 Jul;88(3):170-83 - PubMed
  16. Annu Rev Neurosci. 2008;31:535-61 - PubMed
  17. Dialogues Clin Neurosci. 2010;12(4):554-60 - PubMed
  18. Alcohol Clin Exp Res. 2015 Dec;39(12 ):2403-13 - PubMed
  19. Neuropsychopharmacology. 2007 Oct;32(10):2207-16 - PubMed
  20. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6626-31 - PubMed
  21. Biol Psychiatry. 2017 Jun 1;81(11):900-902 - PubMed
  22. Alcohol Clin Exp Res. 1999 Jan;23(1):164-8 - PubMed
  23. Alcohol Clin Exp Res. 2005 Sep;29(9):1698-705 - PubMed
  24. CNS Neurol Disord Drug Targets. 2012 Aug;11(5):598-609 - PubMed
  25. Curr Opin Neurobiol. 2013 Dec;23(6):921-7 - PubMed
  26. Nat Neurosci. 2015 Jul;18(7):942-52 - PubMed
  27. Glia. 2017 Aug;65(8):1317-1332 - PubMed
  28. Alcohol Alcohol. 2009 Mar-Apr;44(2):136-40 - PubMed
  29. World J Psychiatry. 2016 Mar 22;6(1):31-42 - PubMed
  30. Alcohol Clin Exp Res. 2015 Mar;39(3):455-62 - PubMed
  31. Histochem Cell Biol. 2008 Oct;130(4):635-53 - PubMed
  32. Brain Sci. 2016 Aug 16;6(3):null - PubMed
  33. Mol Psychiatry. 2015 Nov;20(11):1438-47 - PubMed
  34. Lancet. 1993 Nov 13;342(8881):1201-4 - PubMed
  35. Int J Biochem Cell Biol. 2015 Aug;65:134-8 - PubMed
  36. J Am Soc Nephrol. 2011 Oct;22(10):1834-45 - PubMed
  37. Acta Neuropathol Commun. 2013 Jul 25;1:40 - PubMed
  38. Annu Rev Cell Dev Biol. 2014;30:503-33 - PubMed
  39. Neuropsychopharmacology. 2011 Feb;36(3):701-10 - PubMed
  40. Alcohol Clin Exp Res. 1992 Dec;16(6):1078-89 - PubMed
  41. Biol Psychiatry. 2017 Jun 1;81(11):907-917 - PubMed
  42. Brain Behav. 2013 Mar;3(2):114-33 - PubMed
  43. Acta Pharmacol Sin. 2010 Sep;31(9):1044-54 - PubMed
  44. Glia. 2017 Jul;65(7):1021-1031 - PubMed
  45. Gene. 2013 Sep 10;526(2):356-63 - PubMed
  46. Alcohol Clin Exp Res. 1998 Apr;22(2):304-12 - PubMed
  47. Proteomics Clin Appl. 2007 Jan;1(1):62-72 - PubMed
  48. Glia. 2011 Jul;59(7):1064-74 - PubMed
  49. Physiol Rev. 2011 Apr;91(2):603-49 - PubMed
  50. Curr Opin Neurobiol. 2013 Dec;23(6):928-34 - PubMed
  51. Int J Physiol Pathophysiol Pharmacol. 2011;3(1):48-56 - PubMed
  52. J Mol Neurosci. 2008 May;35(1):101-16 - PubMed
  53. Alcohol Clin Exp Res. 2016 Sep;40(9):1802-16 - PubMed
  54. Acta Neuropathol. 2014 Jan;127(1):71-90 - PubMed
  55. J Biomed Sci. 2001 Jan-Feb;8(1):7-19 - PubMed
  56. J Neurochem. 2002 May;81(4):802-13 - PubMed
  57. J Neurosci Res. 2012 Jan;90(1):1-12 - PubMed
  58. Trends Neurosci. 2003 Oct;26(10):523-30 - PubMed
  59. Glia. 2001 Nov;36(2):145-55 - PubMed
  60. Comput Biol Med. 2015 Sep;64:299-306 - PubMed
  61. Physiol Rev. 2001 Apr;81(2):871-927 - PubMed
  62. Life Sci. 1997;61(25):2499-505 - PubMed
  63. Alcohol. 2009 Dec;43(8):627-34 - PubMed
  64. J Neurosci. 2009 Jun 17;29(24):7743-52 - PubMed
  65. Alcohol Alcohol. 2015 Nov;50(6):680-9 - PubMed
  66. Brain Res. 1991 Apr 26;547(1):53-61 - PubMed
  67. Neurosci Biobehav Rev. 2000 May;24(3):295-340 - PubMed
  68. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):503-514 - PubMed
  69. Neurobiol Dis. 2011 Jun;42(3):506-13 - PubMed
  70. J Leukoc Biol. 2005 Dec;78(6):1223-32 - PubMed
  71. Brain Res. 1996 Aug 26;731(1-2):39-44 - PubMed
  72. Nat Rev Neurosci. 2006 Jan;7(1):41-53 - PubMed
  73. Neurobehav Toxicol Teratol. 1986 Jan-Feb;8(1):11-5 - PubMed
  74. Neuroscience. 2015 May 7;293:35-44 - PubMed
  75. J Neurochem. 2014 Feb;128(3):344-9 - PubMed
  76. Ann Neurol. 2009 Mar;65(3):304-15 - PubMed
  77. Addict Biol. 2017 Jul;22(4):1103-1116 - PubMed
  78. Alcohol. 2017 May;60:19-30 - PubMed
  79. Alcohol. 2017 May;60:135-147 - PubMed
  80. Acta Neuropathol Commun. 2013 Jun 12;1:23 - PubMed
  81. Biol Psychiatry. 2013 Apr 1;73(7):613-21 - PubMed
  82. J Anat. 2004 Jun;204(6):475-85 - PubMed
  83. J Comput Assist Tomogr. 1989 May-Jun;13(3):395-8 - PubMed
  84. Biol Psychiatry. 2003 Feb 15;53(4):345-51 - PubMed
  85. Biochem Biophys Res Commun. 2011 Mar 4;406(1):47-52 - PubMed
  86. Am J Psychiatry. 1998 Jun;155(6):726-32 - PubMed
  87. Brain Res Brain Res Rev. 2000 Apr;32(1):29-44 - PubMed
  88. Alcohol Clin Exp Res. 2000 Dec;24(12):1873-82 - PubMed
  89. Trends Neurosci. 2009 Mar;32(3):160-9 - PubMed
  90. J Neurosci. 2008 Apr 2;28(14):3729-37 - PubMed
  91. Epigenetics. 2010 Feb 16;5(2):124-8 - PubMed
  92. Cold Spring Harb Perspect Biol. 2015 Jun 22;8(1):a020479 - PubMed
  93. J Neurosci Res. 2002 Jun 15;68(6):647-54 - PubMed
  94. Alcohol Clin Exp Res. 2006 Nov;30(11):1845-55 - PubMed
  95. Psychopharmacology (Berl). 2011 Apr;214(3):707-18 - PubMed
  96. J Mol Neurosci. 2008 May;35(1):3-12 - PubMed
  97. Alcohol. 2009 Feb;43(1):45-50 - PubMed
  98. Neurochem Int. 2009 Jul-Aug;55(1-3):129-35 - PubMed
  99. J Comp Neurol. 2017 Feb 15;525(3):535-552 - PubMed
  100. J Affect Disord. 2010 Dec;127(1-3):230-40 - PubMed
  101. Neuropharmacology. 2017 Aug 1;122:74-84 - PubMed
  102. Glia. 2001 Jun;34(4):272-82 - PubMed
  103. Neuropharmacology. 2016 Nov;110(Pt B):563-573 - PubMed
  104. Neurosci Lett. 2006 Oct 2;406(1-2):76-80 - PubMed
  105. J Neurochem. 2012 Apr;121(1):4-27 - PubMed
  106. J Neurosci. 2008 Jan 2;28(1):264-78 - PubMed
  107. J Neurosci. 2003 Oct 8;23(27):9254-62 - PubMed
  108. J Neurosci. 1998 May 15;18(10):3620-9 - PubMed
  109. J Neurochem. 2016 Jun;137(5):730-43 - PubMed
  110. Curr Alcohol. 1979;7:83-91 - PubMed
  111. Alcohol. 2017 May;60:95-101 - PubMed
  112. Neuropsychopharmacology. 2013 Feb;38(3):437-45 - PubMed
  113. Glia. 1988;1(3):169-83 - PubMed
  114. Alcohol Alcohol. 2001 Sep-Oct;36(5):357-68 - PubMed
  115. Alcohol Clin Exp Res. 2011 Nov;35(11):1928-37 - PubMed
  116. Brain Res Dev Brain Res. 2002 Nov 15;139(1):29-38 - PubMed
  117. Neuroscience. 1997 Aug;79(4):983-98 - PubMed
  118. Trends Neurosci. 2010 Apr;33(4):193-201 - PubMed
  119. Biol Psychiatry. 2002 Dec 15;52(12):1121-33 - PubMed
  120. Clin Neuropathol. 2000 Jan-Feb;19(1):21-5 - PubMed
  121. Neuropsychopharmacology. 2006 Jul;31(7):1574-82 - PubMed
  122. J Cell Sci. 2006 Nov 1;119(Pt 21):4381-9 - PubMed
  123. Curr Opin Neurobiol. 2016 Aug;39:133-8 - PubMed
  124. J Biomed Sci. 1998 Sep-Oct;5(5):309-20 - PubMed
  125. Neuroimage. 2002 Mar;15(3):708-18 - PubMed
  126. Arch Pharm Res. 2010 Oct;33(10):1467-73 - PubMed
  127. Nat Neurosci. 2006 Feb;9(2):260-7 - PubMed
  128. Alcohol Clin Exp Res. 2004 Nov;28(11):1752-7 - PubMed
  129. Neurosci Lett. 1996 Nov 1;218(2):142-4 - PubMed
  130. Neuroscience. 2014 Sep 26;277:522-40 - PubMed
  131. Glia. 2010 Jan 15;58(2):148-56 - PubMed
  132. PLoS One. 2014 Jul 16;9(7):e101223 - PubMed
  133. J Neurochem. 2014 Nov;131(3):333-47 - PubMed
  134. Alcohol. 2013 Nov;47(7):505-15 - PubMed
  135. J Biomed Sci. 2001 Jan-Feb;8(1):28-36 - PubMed
  136. Alcohol Clin Exp Res. 1999 Jan;23(1):1-6 - PubMed
  137. BMC Genomics. 2013 Oct 22;14:725 - PubMed
  138. J Neurochem. 1997 Dec;69(6):2484-93 - PubMed
  139. Alcohol Clin Exp Res. 2014 Apr;38(4):994-1001 - PubMed
  140. J Neuroimmunol. 2008 Jul 31;198(1-2):82-91 - PubMed
  141. Cold Spring Harb Perspect Biol. 2015 Jul 01;7(9):a020461 - PubMed
  142. Curr Opin Neurobiol. 2010 Oct;20(5):588-94 - PubMed
  143. Acta Neurol Belg. 2002 Dec;102(4):153-7 - PubMed
  144. Front Cell Neurosci. 2017 May 09;11:136 - PubMed
  145. Alcohol Clin Exp Res. 1996 Oct;20(7):1165-72 - PubMed
  146. Alcohol Clin Exp Res. 1997 May;21(3):521-9 - PubMed
  147. Alcohol Clin Exp Res. 2016 Oct;40(10 ):2030-2042 - PubMed
  148. Alcohol Alcohol. 2017 Mar 9;52(2):165-171 - PubMed
  149. Biol Aujourdhui. 2017;211(1):83-91 - PubMed
  150. Alcohol Clin Exp Res. 1994 Jun;18(3):620-4 - PubMed
  151. J Histochem Cytochem. 1989 Feb;37(2):229-40 - PubMed
  152. Acta Histochem. 1995 Jul;97(3):263-71 - PubMed
  153. Mol Psychiatry. 2006 Jan;11(1):56-65 - PubMed
  154. Biochim Biophys Acta. 2013 Jan;1828(1):69-78 - PubMed
  155. Brain Res. 2016 May 1;1638(Pt B):183-198 - PubMed
  156. Glia. 2004 Aug 15;47(3):209-16 - PubMed
  157. Biomed Res Int. 2013;2013:798261 - PubMed
  158. Mol Neurobiol. 1997 Aug;15(1):65-81 - PubMed
  159. Neuroscientist. 2014 Dec;20(6):576-88 - PubMed
  160. Ann N Y Acad Sci. 2008 Oct;1139:10-9 - PubMed
  161. Front Neurosci. 2015 May 20;9:176 - PubMed
  162. Neuron. 2008 Nov 6;60(3):430-40 - PubMed
  163. Physiol Rev. 2018 Jan 1;98 (1):239-389 - PubMed
  164. Neurotox Res. 2012 Jan;21(1):70-8 - PubMed
  165. Curr Biol. 2000 Oct 5;10(19):R712-4 - PubMed
  166. Alcohol Res Health. 2003;27(2):146-52 - PubMed
  167. Brain Res Dev Brain Res. 2001 May 31;128(1):9-16 - PubMed
  168. Neuroscience. 2002;109(1):27-44 - PubMed
  169. Glia. 2012 May;60(6):948-64 - PubMed
  170. Alcohol Res. 2017;38(2):183-206 - PubMed
  171. Neuron. 2017 Dec 20;96(6):1223-1238 - PubMed
  172. Alcohol. 2017 May;60:1-6 - PubMed
  173. Mol Neurobiol. 2012 Feb;45(1):200-12 - PubMed
  174. Alcohol Clin Exp Res. 1988 Feb;12(1):81-7 - PubMed
  175. Nat Med. 2005 Jan;11(1):35-42 - PubMed
  176. Brain Res. 2015 Oct 5;1622:7-21 - PubMed
  177. Alcohol Alcohol. 2015 Mar;50(2):118-31 - PubMed
  178. Neuropsychol Rev. 2012 Jun;22(2):72-80 - PubMed

Publication Types